NFJ Investment Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,953
Closed -$1.87M 282
2025
Q2
$1.87M Sell
5,953
-36
-0.6% -$10.8K 0.07% 208
2025
Q1
$1.82M Hold
5,989
0.06% 203
2024
Q4
$1.99M Sell
5,989
-70
-1% -$23.7K 0.06% 209
2024
Q3
$2.02M Sell
6,059
-282
-4% -$107K 0.06% 209
2024
Q2
$2.61M Sell
6,341
-431
-6% -$171K 0.08% 187
2024
Q1
$2.74M Sell
6,772
-5
-0.1% -$1.76K 0.07% 183
2023
Q4
$2.08M Sell
6,777
-1,436
-17% -$388K 0.06% 183
2023
Q3
$1.99M Sell
8,213
-9,153
-53% -$2.34M 0.06% 180
2023
Q2
$4.17M Sell
17,366
-3,406
-16% -$707K 0.11% 143
2023
Q1
$3.91M Sell
20,772
-2,635
-11% -$545K 0.1% 172
2022
Q4
$4.97M Sell
23,407
-13,289
-36% -$2.65M 0.13% 151
2022
Q3
$8.93M Buy
36,696
+5,349
+17% +$854K 0.23% 152
2022
Q2
$4.69M Buy
31,347
+6,347
+25% +$919K 0.11% 185
2022
Q1
$4.09M Buy
25,000
+8,805
+54% +$1.45M 0.08% 235
2021
Q4
$3.52M Sell
16,195
-764
-5% -$160K 0.06% 259
2021
Q3
$3.21M Buy
16,959
+4,895
+41% +$893K 0.06% 266
2021
Q2
$2.13M Buy
12,064
+3,297
+38% +$569K 0.04% 318
2021
Q1
$1.44M Buy
+8,767
New +$1.34M 0.03% 335

Other funds holding MEDP

NFJ Investment Group's MEDP Position: Q3 2025 in Review

NFJ Investment Group sold out of Medpace (MEDP) in Q3 2025, closing a stake of 5,953 shares — an estimated $1.87M sold.

NFJ Investment Group first reported a position in MEDP in Q1 2021 and held it in 18 quarters. The position peaked at $8.93M in Q3 2022. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • NFJ Investment Group reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • NFJ Investment Group sold 5,953 Medpace shares in Q3 2025, an estimated $1.87M.
  • NFJ Investment Group first reported a position in Medpace in Q1 2021 and held it in 18 quarters.
  • NFJ Investment Group's Medpace position peaked at $8.93M in Q3 2022.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on NFJ Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.